))
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Pharma Intelligence is a leader in the field of healthcare industry information.
Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intell ...
P
Pharma Intelligence Podcasts
In this special podcast from Medtech Insight, editor Reed Miller talked to Andrie Leday, the US vice president for ambulatory surgery centers (ASCs) at Johnson & Johnson/DePuy Synthes. Leday's group is dedicated to creating a new "ecosystem" around DePuy Synthes broad range of orthopedic implants and tools to meet the demand of an aging population.…
Quick Listen: Scrip's Five Must-Know Thingshttps://scrip.pharmaintelligence.informa.com/SC148112/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
P
Pharma Intelligence Podcasts
Pink Sheet reporter and editors discuss Moderna CEO’s Stéphane Bancel’s defense of his company and COVID-19 vaccine pricing at the Senate Health, Education, Labor and Pensions Committee, the NIH denying a petition to use government march-in rights for Xtandi, and Tofersen receiving a positive US FDA advisory committee recommendation for use in ALS.…
P
Pharma Intelligence Podcasts
Pink Sheet reporter and editors discuss Moderna CEO’s Stéphane Bancel’s defense of his company and COVID-19 vaccine pricing at the Senate Health, Education, Labor and Pensions Committee, the NIH denying a petition to use government march-in rights for Xtandi, and Tofersen receiving a positive US FDA advisory committee recommendation for use in ALS.…
P
Pharma Intelligence Podcasts
1
Getting Personal With Brittany Barreto: From One-Time ‘Science Hater’ To Women’s Health Champion
42:05
Medtech Insight sat down with Brittany Barreto, CEO of FemHealth Insights, who participated in a panel discussion at SXSW 2023 on the $1t femtech industry, to talk about her journey to becoming a women’s health care champion.Pharma Intelligence
P
Pharma Intelligence Podcasts
In this episode, HBW Insight catches up with IQVIA Consumer Health’s vice president of Global Consulting Services, Amit Shukla, to find out how the global consumer healthcare market is doing as it comes out of the pandemic. It’s good news, Shukla reveals, based on the firm’s latest intelligence. The market grew double digits in 2022 and is predicte…
P
Pharma Intelligence Podcasts
1
Drug Fix: Medicare Inflation Rebates And Negotiation, Leqembi Reimbursement, FDA Gene Therapy Chief
31:56
Pink Sheet reporter and editors discuss the first round of mandated Medicare inflation rebates and new guidance on price negotiations, consider the VA’s decision to cover the Alzheimer’s drug Leqembi, and the US FDA continuing to search for a cell and gene therapy office leader.Pharma Intelligence
Listen to expert opinions from PPD as they discuss recent survey results which gathered insights on the current and future investment landscape from emerging to mid-size pharmaceutical and biotech companies’ perspectives.Pharma Intelligence
By Ashley Yeo:Interviewing Gabriel Flemming of GTAI, GermanyPharma Intelligence
P
Pharma Intelligence Podcasts
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら 「Chinese Biotechs Ascend Deal-Making By Partnering Up Claudin 18.2 Agents（邦題意訳：中国バイオテック企業が急成長 CLDN18.2抗体で協業続々）」https://scrip.pharmaintelligence.informa.com/SC147989/Chinese-Biotechs-Ascend-DealMaking-By-Partnering-Up-Claudin-182-Agen…
P
Pharma Intelligence Podcasts
In this special extra episode of Medtech Insight's podcast series on cardiovascular technology, editor Reed Miller talked to Vish Charan, the divisional vice president of product development in Abbott's cardiac rhythm management division.[C#4052:Abbott] aspires to be a leader in development of "future-ready" cardiac rhythm management (CRM) devices …
국가신약개발사업단이 제약바이오업계를 지원하기 위해 어떻게 진화하고 있고 어떤 신규 프로젝트를 진행하고 있는 지에 대해 이야기한 묵현상 단장 인터뷰 기사를 요약한 내용입니다.https://scrip.pharmaintelligence.informa.com/SC147745/The-Hunt-For-Big-Fish-How-KDDF-Is-Helping-Create-Korean-DealsPharma Intelligence
Gain valuable insight on the key strategies required to boost patient recruitment and retention rates, and improve diversity, in clinical trials.Pharma Intelligence
P
Pharma Intelligence Podcasts
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights how Alife Health is using its AI-based platform for IVF to increase chances for successful pregnancies while Barnaby Pickering discusses how AI Medical Technology is using AI to detect melanoma. Reed Miller talks about weight-loss device maker Allurion Technologies’ si…
P
Pharma Intelligence Podcasts
In this episode of Medtech Connect, Medtech Insight regulatory reporter Hannah Daniel interviews Scott Trevino, senior vice president of cybersecurity at TRIMEDX about the new cybersecurity oversight given to the FDA as a part of the 2023 Omnibus Appropriations bill passed in December.Pharma Intelligence
Why does your organization need an electronic quality management system (eQMS)? What are the uses of an eQMS and how can you ensure you’re reaping its full benefits? Listen in as experts from IQVIA discuss “How to Successfully Deploy a Fully Integrated eQMS”.Pharma Intelligence
P
Pharma Intelligence Podcasts
Listen in on an illuminating and informative discussion about the role of AI in the medtech and pharma industries. Experts from IQVIA and Microsoft share their perspectives on AI’s benefits, its barriers to use, and its almost limitless possibilities for medicine.Pharma Intelligence
Listen in as experts from IQVIA discuss the benefits of implementing an eQMS (electronic quality management system) in service of improving and automating computer system validation (CSV).Pharma Intelligence
P
Pharma Intelligence Podcasts
In this episode, HBW Insight chats with UK PR firm Kaizo’s associate director Kerry Lennox about consumer healthcare marketing in the post-pandemic context. With consumers bombarded by healthcare messaging and increasingly anxious about their health and wellness, Lennox explains how OTC firms can play a key role in supporting them to self-care resp…
P
Pharma Intelligence Podcasts
Pink Sheet reporters and editors discuss US FDA advisory committee members’ concerns about two proposed RSV vaccines, Lilly’s plan to lower the cost of its insulin products, proposed changes to the Orphan Drug Act and the departure of the influential leader of the FDA’s Office of Neuroscience.Pharma Intelligence
P
Pharma Intelligence Podcasts
In this episode of Medtech Insight’s new podcast series focused on cardiovascular technology, editor Reed Miller talked to Christopher Piorkowski, Abbott's chief medical officer for electrophysiology.Recent Medtech Insight articles related to this interview:US FDA Approves Abbott’s Sensor-Enabled TactiCath AF CatheterAbbott Launches Next-Generation…
P
Pharma Intelligence Podcasts
1
Getting Personal With Boston’s Scientific Global CMO Ken Stein: Taking The Long View To Innovate
37:30
In this new series titled Getting Personal, we talk to new and veteran senior executives about their journeys to corporate leadership, their motivations, passions, and the peaks and valleys of running a medtech company. Medtech Insight talked with Ken Stein, Boston Scientific’s global chief medical officer about his own diagnosis with atrial fibril…
P
Pharma Intelligence Podcasts
hVIVO’s Andrew Catchpole Talks Human Challenge Trials, From COVID-19 to Malaria by Pharma IntelligencePharma Intelligence
Citeline’s Brian Yang and Dexter Yan discuss recent China biotech hot topics incl. antibody drug conjugate deals, China’s planning to ban gene editing export, volume-based procurement in 2023 and China biotech’s paradox and outlooks in the new year of rabbit.https://scrip.pharmaintelligence.informa.com/SC147973/Chinese-Language-Podcast--ADC…
P
Pharma Intelligence Podcasts
Pink Sheet reporters and editor discuss learnings from a generic drug industry trade association conference, as well as FDA Commissioner Robert Califf’s ideas for advisory committee changes and using emergency use authorizations in non-COVID-19 areas.Pharma Intelligence
P
Pharma Intelligence Podcasts
OxSonics Hopes To Use Ultrasound To Enhance Drug Efficacy – Without Reformulation by Pharma IntelligencePharma Intelligence
P
Pharma Intelligence Podcasts
Citeline managing editor Brain Yang discusses with Insilico Co-CEO and Head of Drug Discovery Feng Ren on artificial intelligence-assisted drug discovery for idiopathic pulmonary fibrosis.https://scrip.pharmaintelligence.informa.com/SC147940/AI-ChatGPT-And-The-Future-Of-Drug-Discovery-China-Biotech-CEO-Podcast-WIth-Insilicos-CoCEO…
This podcast is the second installment of the conversation between Citeline and Quest Diagnostics. This conversation explores the challenges sponsors face when identifying trial sites and principal investigators and the importance of identifying the right sites and principal investigators for clinical trials.…
This podcast explores the challenges sponsors face when identifying trial sites and principal investigators and the importance of identifying the right sites and principal investigators for clinical trials.Pharma Intelligence
China’s Akeso has made a name for itself on the world stage by cutting a potential $5bn licensing deal with US biotech Summit in December 2022. Michelle Xia, founder, chairwoman and CEO of the biopharma, is beginning to look beyond the deal, describing it one of the first steps for Akeso to develop and commercialize innovative drugs globally on its…
P
Pharma Intelligence Podcasts
In this episode, HBW Insight catches up with director general of the Association of the European Self-Care Industry, Jurate Švarcaite, to find out about the association’s upcoming Annual Meeting. Taking place in Paris, France, between the 22nd and 24th May, the meeting begins with a networking cruise along the river Seine and ends with a series of …
https://scrip.pharmaintelligence.informa.com/SC147933/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
Quick Listen: Scrip’s Five Must-Know Things:https://scrip.pharmaintelligence.informa.com/SC147899/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
P
Pharma Intelligence Podcasts
1
Drug Fix: Limiting Medicare Price Negotiation, More US FDA Adcomm And COVID-19 Vaccine Concerns
37:05
Pink Sheet reporters and editors discuss the impact of PhRMA’s new push to limit Medicare price negotiations, Congress’ interest in FDA advisory committee reforms, and concerns about the COVID-19 vaccine strain selection process.Pharma Intelligence
P
Pharma Intelligence Podcasts
Announcing the 2nd Citeline Pharma Intelligence Awards Japan, which will take place in Tokyo on 17 October. Entries are now open with a deadline of 10 July. Check out the links below for all the information on categories, judges, how to enter, table bookings and sponsorship opportunities. See you in Tokyo! English-language event site is here:https:…
P
Pharma Intelligence Podcasts
The future of mifepristone in America, with professor Greer Donley by Pharma IntelligencePharma Intelligence
P
Pharma Intelligence Podcasts
DMHC’s financial analysts discuss M&As, the vaccine market, and biosimilars by Pharma IntelligencePharma Intelligence
올해 글로벌 제약바이오 업계의 자금조달 환경을 전망한 Scrip 기사를 요약한 내용입니다.https://scrip.pharmaintelligence.informa.com/SC147593/Scrip-AsksWhat-Does-2023-Hold-For-Biopharma-Part-1-The-Funding-EnvironmentPharma Intelligence
Inside medical research charity LifeArc, with CEO Melanie Lee by Pharma IntelligencePharma Intelligence
P
Pharma Intelligence Podcasts
1
Prebiotics And Consumer Health: Opportunity, Regulation and Future, With Clasado’s Per Rehné
33:04
In this episode, HBW Insight interviews Per Rehné, CEO of UK-based microbiome specialists Clasado Biosciences, about the exciting world of prebiotics. Essentially food for your gut microbiome, prebiotics have benefitted from a worldwide boom in preventative health in recent years, as well as a critical mass of clinical research showing the signific…
Quick Listen: Scrip's Five Must-Know Thingshttps://scrip.pharmaintelligence.informa.com/SC147859/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
P
Pharma Intelligence Podcasts
1
Drug Fix: US FDA Loses Gene Therapy Expert, Humira Biosimilars Launch, FDA Allows In-Person Meetings
31:31
Pink Sheet reporters and editors consider the impact of FDA Office of Tissues and Advanced Therapies Director Wilson Bryan’s retirement, the launch of Humira biosimilars and its effect on the biologic market, as well as the FDA moving to hybrid meetings with sponsors.Pharma Intelligence
P
Pharma Intelligence Podcasts
In this episode of new podcast series Medtech Connect, Medtech Insight’s regulatory writer for Europe, Eliza Slawther, interviews Alexander Olbrechts, director for digital health at the European trade body Medtech Europe, to find out more about the proposed European Health Data Space initiative and what it means for the medical device industry.…
Genexine’s Neil Warma talks to Scrip’s Jung Won Shin about the company’s strategy, pipeline and plans and the wider environment for Korean biopharma firms looking to go global.From Science To Commercialization: How Genexine Is Making The Shifthttps://scrip.pharmaintelligence.informa.com/SC147834/From-Science-To-Commercialization-How-Genexine-Is-Mak…
P
Pharma Intelligence Podcasts
1
Biotech Is Solving Beauty’s Sustainability Challenges, Elevating R&D, With Amyris’ Annie Tsong
20:43
In this episode, HBW Insight chats with Annie Tsong, chief strategy and product officer at Amyris, Inc., an Emeryville, Calif.-based company that uses synthetic biotechnology to produce clean beauty, personal care, wellness and food ingredients for thousands of brands across the globe. Leading the firm’s ingredient development pipeline, Tsong discu…
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「J.P. Morgan Was Back, But Not With A Roar（邦題意訳：帰ってきたJPモルガンカンファレンス、ただし勢いはやや控えめ）」https://scrip.pharmaintelligence.informa.com/SC147649/JP-Morgan-Was-Back-But-Not-With-A-Roar「The Best Of J.P. Morgan – Valuations, Deals And The IRA（邦題意訳：…
Quick Listen: Scrip's Five Must-Know Thingshttps://scrip.pharmaintelligence.informa.com/SC147782/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
Eli Lilly’s Diogo Rau on the company’s digital future by Pharma IntelligencePharma Intelligence
P
Pharma Intelligence Podcasts
Dr. Cronin provides her perspectives on identification, treatment, and management of oHCM patients using the novel cardiac myosin inhibitor, mavacamten.Lynn Cronin, MD, FACC is board-certified in cardiology with clinical interests in adult congenital heart disease, valvular heart disease, and chronic ischemic heart disease. She is affiliated with m…
P
Pharma Intelligence Podcasts
1
Digital Health Roundup: CES 2023 Highlights; US FDA VR, AR Website; Bayer’s Powers Up On Radiology
10:15
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent CES 2023 conference in Las Vegas. Reed Miller discusses Abbott’s VR partnership with the Blood Centers for America and Barnaby Pickering highlights Bayer’s jump into medtech with its buyout of Blackford Analysis.Listen to the podcast via the pl…
